SCHEMBL24897797

SCHEMBL24897797

CC(=O)C[C@](C)(N)COc1ccc(-c2ccnc(C(F)F)c2)nc1C(F)F

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AAK1 Q2M2I8 20/20 0.73
GAK O14976 4/20 0.73
BMP2K Q9NSY1 4/20 0.73
CIT O14578 3/20 0.73
MKNK1 Q9BUB5 3/20 0.73
SLC6A2 P23975 2/20 0.73
KCNH2 Q12809 2/20 0.73
LATS2 Q9NRM7 1/20 0.73
ABCG2 Q9UNQ0 1/20 0.73
MKNK2 Q9HBH9 3/20 0.58
ROCK2 O75116 2/20 0.58
DAPK3 O43293 1/20 0.58
JAK2 O60674 1/20 0.58
DAPK1 P53355 1/20 0.58
TYRO3 Q06418 1/20 0.58
DMPK Q09013 1/20 0.58
HIPK4 Q8NE63 1/20 0.58
CYP3A4 P08684 2/20 0.51
PRKG2 Q13237 2/20 0.51
PKN2 Q16513 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24897677 1.00 AAK1 (0.73) AAK1GAKBMP2KCITMKNK1
SCHEMBL30804936 1.00 AAK1 (0.73) AAK1GAKBMP2KCITMKNK1
SCHEMBL30804940 1.00 AAK1 (0.73) AAK1GAKBMP2KCITMKNK1
SCHEMBL30185653 0.90 AAK1 (0.73) AAK1GAKBMP2KCITMKNK1
SCHEMBL24897659 0.90 AAK1 (0.73) AAK1GAKBMP2KCITMKNK1
SCHEMBL30185639 0.90 AAK1 (0.73) AAK1GAKBMP2KCITMKNK1
SCHEMBL24897596 0.90 AAK1 (0.73) AAK1GAKBMP2KCITMKNK1
SCHEMBL24897796 0.90 AAK1 (0.73) AAK1GAKBMP2KCITMKNK1
SCHEMBL30185632 0.90 AAK1 (0.73) AAK1GAKBMP2KCITMKNK1
SCHEMBL24897830 0.86 AAK1 (0.76) AAK1GAKBMP2KCITMKNK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240343720-A1 AAK1 INHIBITOR AND USE THEREOF XIZANG HAISCO PHARMACEUTICAL CO., LTD. (CN) 2024-10-17 US disclosed
EP-4371980-A1 AAK1 INHIBITOR AND USE THEREOF Xizang Haisco Pharmaceutical Co., Ltd. (CN) 2024-05-22 EP disclosed
CN-117715899-A AAK1 inhibitors and uses thereof 西藏海思科制药有限公司 2024-03-15 CN disclosed
WO-2023284838-A1 AAK1 INHIBITOR AND USE THEREOF 四川海思科制药有限公司 2023-01-19 WO disclosed
WO-2023284838-A1 AAK1 INHIBITOR AND USE THEREOF 四川海思科制药有限公司 2023-01-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240343720-A1 AAK1 INHIBITOR AND USE THEREOF AAK1, ADCK1, ADCK5 AAK1 1/4885GAK 131/4885BMP2K 440/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.